• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过促进侵袭、细胞命运和细胞骨架改变以及上皮-间质转化,是侵袭性前列腺癌的一个驱动因素。

is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.

作者信息

Francis Jeffrey C, Capper Amy, Ning Jian, Knight Eleanor, de Bono Johann, Swain Amanda

机构信息

Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK.

Tumour Profiling Unit, The Institute of Cancer Research, London SW3 6JB, UK.

出版信息

Oncotarget. 2018 Jan 10;9(7):7604-7615. doi: 10.18632/oncotarget.24123. eCollection 2018 Jan 26.

DOI:10.18632/oncotarget.24123
PMID:29484136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5800928/
Abstract

Aggressive lethal prostate cancer is characterised by tumour invasion, metastasis and androgen resistance. Understanding the mechanisms by which localised disease progresses to advanced lethal stages is key to the development of effective therapies. Here we have identified a novel role for the transcription factor, SOX9, as a driver of aggressive invasive prostate cancer. Using genetically modified mouse models, we show that increased expression in the prostate epithelia of animals with loss leads to a highly invasive phenotype and metastasis. In depth analysis of these mice and related models reveals that SOX9 acts a key regulator of various processes that together promote tumour progression. We show that this factor promotes cell lineage plasticity with cells acquiring properties of basal stem cells and an increase in proliferation. In addition, increased SOX9 leads to changes in cytoskeleton and adhesion, deposition of extracellular matrix and epithelia to mesenchyme transition, properties of highly invasive cells. Analysis of castrated mice showed that the invasive phenotype driven by SOX9 is independent of androgen levels. Our study has identified a novel driver of prostate cancer progression and highlighted the cellular and molecular processes that are regulated by to achieve invasive disease.

摘要

侵袭性致死性前列腺癌的特征是肿瘤侵袭、转移和雄激素抵抗。了解局限性疾病进展为晚期致死阶段的机制是开发有效治疗方法的关键。在此,我们确定了转录因子SOX9在侵袭性前列腺癌发展过程中的新作用。通过基因改造小鼠模型,我们发现,在缺失的动物前列腺上皮细胞中SOX9表达增加会导致高度侵袭性表型和转移。对这些小鼠及相关模型的深入分析表明,SOX9是共同促进肿瘤进展的各种过程的关键调节因子。我们发现,该因子可促进细胞谱系可塑性,使细胞获得基底干细胞特性并增加增殖。此外,SOX9表达增加会导致细胞骨架和黏附的变化、细胞外基质的沉积以及上皮-间质转化,这些都是高侵袭性细胞的特性。对去势小鼠的分析表明,由SOX9驱动的侵袭性表型与雄激素水平无关。我们的研究确定了前列腺癌进展的一个新驱动因素,并突出了由SOX9调控以实现侵袭性疾病的细胞和分子过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/68755f42f8f8/oncotarget-09-7604-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/4ddcd70648a4/oncotarget-09-7604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/063d2ab7e82a/oncotarget-09-7604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/6275fe752f49/oncotarget-09-7604-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/75c60c408b01/oncotarget-09-7604-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/d30c4d1f22ec/oncotarget-09-7604-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/68755f42f8f8/oncotarget-09-7604-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/4ddcd70648a4/oncotarget-09-7604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/063d2ab7e82a/oncotarget-09-7604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/6275fe752f49/oncotarget-09-7604-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/75c60c408b01/oncotarget-09-7604-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/d30c4d1f22ec/oncotarget-09-7604-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9dae/5800928/68755f42f8f8/oncotarget-09-7604-g006.jpg

相似文献

1
is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.通过促进侵袭、细胞命运和细胞骨架改变以及上皮-间质转化,是侵袭性前列腺癌的一个驱动因素。
Oncotarget. 2018 Jan 10;9(7):7604-7615. doi: 10.18632/oncotarget.24123. eCollection 2018 Jan 26.
2
Stem Cell Determinant SOX9 Promotes Lineage Plasticity and Progression in Basal-like Breast Cancer.干细胞决定因子 SOX9 促进基底样乳腺癌中的谱系可塑性和进展。
Cell Rep. 2020 Jun 9;31(10):107742. doi: 10.1016/j.celrep.2020.107742.
3
SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.SOX9 在前列腺中的升高促进了细胞增殖,并与 PTEN 缺失协同作用驱动肿瘤形成。
Cancer Res. 2010 Feb 1;70(3):979-87. doi: 10.1158/0008-5472.CAN-09-2370. Epub 2010 Jan 26.
4
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.基质的环境和细胞力学特性调节细胞迁移,并有助于癌细胞的侵袭表型。
Rep Prog Phys. 2019 Jun;82(6):064602. doi: 10.1088/1361-6633/ab1628. Epub 2019 Apr 4.
5
TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.TGF-β1-SOX9 轴诱导的 COL10A1 通过上皮-间充质转化促进胃癌的侵袭和转移。
Cell Death Dis. 2018 Aug 28;9(9):849. doi: 10.1038/s41419-018-0877-2.
6
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer.Sox9 一过性表达促进前列腺癌对雄激素靶向治疗的抵抗。
Clin Cancer Res. 2020 Apr 1;26(7):1678-1689. doi: 10.1158/1078-0432.CCR-19-0098. Epub 2020 Jan 9.
7
Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis.Yap-Sox9 信号通路决定了肝细胞的可塑性和谱系特异性肝癌发生。
J Hepatol. 2022 Mar;76(3):652-664. doi: 10.1016/j.jhep.2021.11.010. Epub 2021 Nov 15.
8
ASCL1 represses a SOX9 neural crest stem-like state in small cell lung cancer.ASCL1 在小细胞肺癌中抑制 SOX9 神经嵴干细胞样状态。
Genes Dev. 2021 Jun;35(11-12):847-869. doi: 10.1101/gad.348295.121. Epub 2021 May 20.
9
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.SOX9表达缺失与ERG阳性且PTEN缺失的前列腺癌中的前列腺特异性抗原复发相关。
PLoS One. 2015 Jun 1;10(6):e0128525. doi: 10.1371/journal.pone.0128525. eCollection 2015.
10
A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.一种罕见的去势抵抗性祖细胞群在Pten基因缺失的前列腺肿瘤中高度富集。
J Pathol. 2017 Sep;243(1):51-64. doi: 10.1002/path.4924. Epub 2017 Jul 28.

引用本文的文献

1
Neuroendocrine Differentiation in Prostate Cancer Requires ASCL1.前列腺癌中的神经内分泌分化需要 ASCL1。
Cancer Res. 2024 Nov 4;84(21):3522-3537. doi: 10.1158/0008-5472.CAN-24-1388.
2
Identification of genes that promote PI3K pathway activation and prostate tumour formation.鉴定促进 PI3K 通路激活和前列腺肿瘤形成的基因。
Oncogene. 2024 Jun;43(24):1824-1835. doi: 10.1038/s41388-024-03028-x. Epub 2024 Apr 23.
3
SOX9 knockout decreases stemness properties in colorectal cancer cells.SOX9基因敲除可降低结肠癌细胞的干性特性。

本文引用的文献

1
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.SOX2促进TP53和RB1缺陷型前列腺癌中的谱系可塑性和抗雄激素耐药性。
Science. 2017 Jan 6;355(6320):84-88. doi: 10.1126/science.aah4307.
2
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.Rb1和Trp53协同作用以抑制前列腺癌的谱系可塑性、转移和抗雄激素耐药性。
Science. 2017 Jan 6;355(6320):78-83. doi: 10.1126/science.aah4199.
3
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer.
J Gastrointest Oncol. 2023 Aug 31;14(4):1735-1745. doi: 10.21037/jgo-22-1163. Epub 2023 Jun 29.
4
Cancer Stem Cells-The Insight into Non-Coding RNAs.癌症干细胞——非编码 RNA 的新视角。
Cells. 2022 Nov 21;11(22):3699. doi: 10.3390/cells11223699.
5
SOX9 Protein in Pancreatic Cancer Regulates Multiple Cellular Networks in a Cell-Specific Manner.胰腺癌中的SOX9蛋白以细胞特异性方式调节多个细胞网络。
Biomedicines. 2022 Jun 21;10(7):1466. doi: 10.3390/biomedicines10071466.
6
A Review of Prostate Organogenesis and a Role for iPSC-Derived Prostate Organoids to Study Prostate Development and Disease.前列腺发生的研究综述及 iPSC 衍生的前列腺类器官在研究前列腺发育和疾病中的作用。
Int J Mol Sci. 2021 Dec 3;22(23):13097. doi: 10.3390/ijms222313097.
7
Epithelial-mesenchymal transition and its transcription factors.上皮-间充质转化及其转录因子。
Biosci Rep. 2022 Jan 28;42(1). doi: 10.1042/BSR20211754.
8
The Clinicopathological and Prognostic Significance of SOX9 Expression in Gastric Cancer: Meta-Analysis and TCGA Analysis.SOX9表达在胃癌中的临床病理及预后意义:荟萃分析与TCGA分析
Front Oncol. 2021 Sep 9;11:668946. doi: 10.3389/fonc.2021.668946. eCollection 2021.
9
A proteomic investigation of isogenic radiation resistant prostate cancer cell lines.同源辐射抗性前列腺癌细胞系的蛋白质组学研究。
Proteomics Clin Appl. 2021 Sep;15(5):e2100037. doi: 10.1002/prca.202100037. Epub 2021 Jun 30.
10
Sex determining region Y-box 9 induced microtubule formation and epithelial⁃mesenchymal transition in human oral squamous cell carcinoma CAL27 cells.性别决定区 Y 框 9 诱导人口腔鳞状细胞癌细胞 CAL27 中微管形成和上皮⁃间充质转化。
Hua Xi Kou Qiang Yi Xue Za Zhi. 2021 Feb 1;39(1):74-80. doi: 10.7518/hxkq.2021.01.011.
干细胞和神经源性基因表达谱将前列腺基底细胞与侵袭性前列腺癌联系起来。
Nat Commun. 2016 Feb 29;7:10798. doi: 10.1038/ncomms10798.
4
A basal stem cell signature identifies aggressive prostate cancer phenotypes.一种基底干细胞特征可识别侵袭性前列腺癌表型。
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6544-52. doi: 10.1073/pnas.1518007112. Epub 2015 Oct 12.
5
Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion.Sox9 控制癌基因靶向细胞的自我更新,并将肿瘤起始和浸润联系起来。
Cell Stem Cell. 2015 Jul 2;17(1):60-73. doi: 10.1016/j.stem.2015.05.008. Epub 2015 Jun 18.
6
Prostate cancer.前列腺癌。
Lancet. 2016 Jan 2;387(10013):70-82. doi: 10.1016/S0140-6736(14)61947-4. Epub 2015 Jun 11.
7
Integrative clinical genomics of advanced prostate cancer.晚期前列腺癌的整合临床基因组学
Cell. 2015 May 21;161(5):1215-1228. doi: 10.1016/j.cell.2015.05.001.
8
Molecular mechanisms of epithelial-mesenchymal transition.上皮-间质转化的分子机制。
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96. doi: 10.1038/nrm3758.
9
Palladin regulation of the actin structures needed for cancer invasion.帕拉丁调节癌症侵袭所需的肌动蛋白结构。
Cell Adh Migr. 2014;8(1):29-35. doi: 10.4161/cam.28024. Epub 2013 Jan 1.
10
Tumour heterogeneity and cancer cell plasticity.肿瘤异质性和癌细胞可塑性。
Nature. 2013 Sep 19;501(7467):328-37. doi: 10.1038/nature12624.